NNE A/S
Core data
Name | NNE A/S |
Address | Bredevej 2, 2830, Virum |
Founded | Jul 1, 1989 |
| 1,748 / 1,704 | |
Locations (P-units) | 2View locations |
Website | https://www.nne.com/offices/nne-in-denmark/ |
| nne | |
Branch | Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik (711220) |
Name | NNE A/S |
Address | Bredevej 2, 2830, Virum |
Founded | Jul 1, 1989 |
| 1,748 / 1,704 |
Locations (P-units) | 2View locations |
Website | https://www.nne.com/offices/nne-in-denmark/ |
| nne | |
Branch | Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik (711220) |
Keep track of NNE A/S
Description
NNE is an independent company delivering expert pharma engineering services to pharmaceutical and biotech customers, with a focus on API pharma engineering and end-to-end project execution.
NNE provides fast, adaptable, end-to-end and cross-disciplinary pharma engineering services, including planning and establishing new pharmaceutical facilities, upgrades, expansions, and ongoing support of existing operations.
Company's own description on virk.dk
What we doWe provide end-to-end pharma engineering services Our core services cover design (conceptual and basic design) and EPCMV (detailed design, procurement, construction management, commissioning and qualication). The NNE project model provides the framework for how we work, both on large CapEx expansions and smaller optimisation projects. We also use our experience to offer various advisory services (e.g. customer representation, execution and discipline support) as required by our customers. Conceptual designBasic designDetailed designNNE conducts NNE creates NNE and the front-end studies explanations, customer rene the and customer drawings and design, and create workshops to gain specications that plans and models for insights and create demonstrate the the nal phases and simple design nal designsbasis for tenderssolutionsProcurementConstructionCommissioning and qualicationNNE develops a NNE plans, procurement strategy, coordinates and NNE veries executes the tender manages the and documents process, negotiates, construction of the that design selects contractors new facility or requirements and nalises the facility upgrade and stakeholder contractsaccording to the expectations have design solutionbeen met prior to handover
Products & services
API pharma engineering · End-to-end project execution · Planning and establishment of new pharma facilities · Facility upgrades and expansions · Ongoing support of existing operations
Industries
Pharmaceutical engineering · Biotechnology
Customer types
Pharmaceutical customers · Biotech customers
Customers & references
Novo Nordisk
Financials
| Reporting period | 2025DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,555,648,000 | ||||||||
| Gross profit | 681,331,000 | ||||||||
| Operating profit | 529,793,000 | ||||||||
| Profit before tax | 508,098,000 | ||||||||
| Net income | 385,296,000 | ||||||||
| Total assets | 1,611,493,000 | ||||||||
| Equity | 670,320,000 | ||||||||
| Avg. employees | 1,542 | ||||||||
2017–2025 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Ines Areizaga Esteva | Roles Board | TitlesBESTYRELSESMEDLEM |
| Jan Hoff | Roles Board | TitlesBESTYRELSESMEDLEM |
| Jesper Schultz Fredsted | Roles Board | TitlesSUPPLEANT |
| Karsten Munk Knudsen | Roles Board | TitlesFORMAND |
| Karsten Skytte Dencker | Roles Board | TitlesSUPPLEANT |
| Lars Lundberg Kristensen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Michael Fugl Hallgren | Roles Board | TitlesBESTYRELSESMEDLEM |
| Christoffer Hviid | Roles Management | TitlesDIREKTØR |
| Jesper Kløve | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Deloitte Statsautoriseret Revisionspartnerselskab | AuditorMartin Pieper | RoleState Authorised Public Accountant | FromMar 30, 2026 |
| DeloitteStatsautoriseret Revisionspartnerselskab | AuditorNiels Skannerup Vendelbo | RoleState Authorised Public Accountant | FromMar 30, 2026 |
| DeloitteStatsautoriseret Revisionspartnerselskab | AuditorSumit Sudan | RoleState-Authorised Public Accountant | FromMar 30, 2026 |
| — | AuditorAnders Vad Dons | RoleState-Authorised Public Accountant | FromMar 30, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromJul 1, 1989 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| NOVO NORDISK FONDEN | Ownership through | 25–33.32 % |